Terms: = Breast cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Diagnosis
26 results:
1. Sarcoma care in the era of precision medicine.
Wallander K; Öfverholm I; Boye K; Tsagkozis P; Papakonstantinou A; Lin Y; Haglund de Flon F
J Intern Med; 2023 Dec; 294(6):690-707. PubMed ID: 37643281
[TBL] [Abstract] [Full Text] [Related]
2. Clinical and Genomic Characteristics of Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic breast cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors.
Rao X; Chen Y; Beyrer J; Nash Smyth E; Morato Guimaraes C; Litchfield LM; Bowman L; Lawrence GW; Aggarwal A; Andre F
Clin Cancer Res; 2023 Sep; 29(17):3372-3383. PubMed ID: 37289194
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive genomic profiling of a unique liposarcoma arising in a patient with Li-Fraumeni syndrome and the novel detection of c-myc amplification: a case report.
Watanabe H; Fujishima F; Motoi T; Aoyama Y; Niihori T; Takahashi M; Umegaki S; Oishi H; Tada H; Ichinohasama R; Sasano H
Diagn Pathol; 2022 Dec; 17(1):93. PubMed ID: 36514176
[TBL] [Abstract] [Full Text] [Related]
4. MIR4435-2HG Is a Potential Pan-cancer Biomarker for diagnosis and Prognosis.
Zhong C; Xie Z; Zeng LH; Yuan C; Duan S
Front Immunol; 2022; 13():855078. PubMed ID: 35784328
[TBL] [Abstract] [Full Text] [Related]
5. Pimozide inhibits the growth of breast cancer cells by alleviating the Warburg effect through the P53 signaling pathway.
Li J; Qu P; Zhou XZ; Ji YX; Yuan S; Liu SP; Zhang QG
Biomed Pharmacother; 2022 Jun; 150():113063. PubMed ID: 35658233
[TBL] [Abstract] [Full Text] [Related]
6. Nuclear delivery of dual anti-cancer drugs by molecular self-assembly.
Wu J; Ding W; Han G; You W; Gao W; Shen H; Tang J; Tang Q; Wang X
Biomater Sci; 2021 Jan; 9(1):116-123. PubMed ID: 33325919
[TBL] [Abstract] [Full Text] [Related]
7. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.
Schiano C; Soricelli A; De Nigris F; Napoli C
Expert Rev Clin Immunol; 2019 Mar; 15(3):289-301. PubMed ID: 30570412
[TBL] [Abstract] [Full Text] [Related]
8. FISH analysis of selected soft tissue tumors: Diagnostic experience in a tertiary center.
Vargas AC; Selinger C; Satgunaseelan L; Cooper WA; Gupta R; Stalley P; Brown W; Soper J; Schatz J; Boyle R; Thomas DM; Tattersall MHN; Bhadri V; Maclean F; Bonar SF; Scolyer RA; Karim RZ; McCarthy SW; Mahar A; O'Toole SA
Asia Pac J Clin Oncol; 2019 Feb; 15(1):38-47. PubMed ID: 29806089
[TBL] [Abstract] [Full Text] [Related]
9. Primary breast Atypical Lipomatous Tumor/ Well-Differentiated Liposarcoma and Dedifferentiated Liposarcoma.
Briski LM; Jorns JM
Arch Pathol Lab Med; 2018 Feb; 142(2):268-274. PubMed ID: 29372852
[TBL] [Abstract] [Full Text] [Related]
10. p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
Macedo GS; Vieira IA; Vianna FSL; Alemar B; Giacomazzi J; Brandalize APC; Caleffi M; Volc SM; de Campos Reis Galvão H; Palmero EI; Achatz MI; Ashton-Prolla P
Fam Cancer; 2018 Apr; 17(2):269-274. PubMed ID: 28756477
[TBL] [Abstract] [Full Text] [Related]
11. Mammary-type Myofibroblastoma: Clinicopathologic Characterization in a Series of 143 Cases.
Howitt BE; Fletcher CD
Am J Surg Pathol; 2016 Mar; 40(3):361-7. PubMed ID: 26523539
[TBL] [Abstract] [Full Text] [Related]
12. Periductal Stromal Sarcoma of the breast With Liposarcomatous Differentiation: A Case Report With 10-Year Follow-up and Literature Review.
White SR; Auguste LJ; Guo H; Bhuiya T
Int J Surg Pathol; 2015 May; 23(3):221-4. PubMed ID: 25614463
[TBL] [Abstract] [Full Text] [Related]
13. Retroperitoneal dedifferentiated liposarcoma lacking mdm2 amplification in a patient with a germ line CHEK2 mutation.
Sadri N; Surrey LF; Fraker DL; Zhang PJ
Virchows Arch; 2014 Apr; 464(4):505-9. PubMed ID: 24595525
[TBL] [Abstract] [Full Text] [Related]
14. SNP285C modulates oestrogen receptor/Sp1 binding to the mdm2 promoter and reduces the risk of endometrial but not prostatic cancer.
Knappskog S; Trovik J; Marcickiewicz J; Tingulstad S; Staff AC; ; Romundstad P; Hveem K; Vatten L; Salvesen HB; Lønning PE
Eur J Cancer; 2012 Sep; 48(13):1988-96. PubMed ID: 22119201
[TBL] [Abstract] [Full Text] [Related]
15. Association of the germline TP53 R72P and mdm2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.
van den Broek AJ; Broeks A; Horlings HM; Canisius SV; Braaf LM; Langerød A; Van't Veer LJ; Schmidt MK
Breast Cancer Res Treat; 2011 Nov; 130(2):599-608. PubMed ID: 21667122
[TBL] [Abstract] [Full Text] [Related]
16. Involvement of p53 R72P polymorphism in the association of mdm2-SNP309 with breast cancer.
Leu JD; Wang CY; Tsai HY; Lin IF; Chen RC; Lee YJ
Oncol Rep; 2011 Jun; 25(6):1755-63. PubMed ID: 21479369
[TBL] [Abstract] [Full Text] [Related]
17. mdm2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk.
Knappskog S; Lønning PE
Oncotarget; 2011 Mar; 2(3):251-8. PubMed ID: 21436469
[TBL] [Abstract] [Full Text] [Related]
18. The mdm2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians.
Knappskog S; Bjørnslett M; Myklebust LM; Huijts PE; Vreeswijk MP; Edvardsen H; Guo Y; Zhang X; Yang M; Ylisaukko-Oja SK; Alhopuro P; Arola J; Tollenaar RA; van Asperen CJ; Seynaeve C; Staalesen V; Chrisanthar R; Løkkevik E; Salvesen HB; Evans DG; Newman WG; Lin D; Aaltonen LA; Børresen-Dale AL; Tell GS; Stoltenberg C; Romundstad P; Hveem K; Lillehaug JR; Vatten L; Devilee P; Dørum A; Lønning PE
Cancer Cell; 2011 Feb; 19(2):273-82. PubMed ID: 21316605
[TBL] [Abstract] [Full Text] [Related]
19. A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer.
Kulkarni DA; Vazquez A; Haffty BG; Bandera EV; Hu W; Sun YY; Toppmeyer DL; Levine AJ; Hirshfield KM
Carcinogenesis; 2009 Nov; 30(11):1910-5. PubMed ID: 19762336
[TBL] [Abstract] [Full Text] [Related]
20. The significance of mdm2 SNP309 and p53 Arg72Pro in young women with breast cancer.
Lång A; Palmebäck Wegman P; Wingren S
Oncol Rep; 2009 Sep; 22(3):575-9. PubMed ID: 19639206
[TBL] [Abstract] [Full Text] [Related]
[Next]
